Clinical Trial

A Study of CM512 in Patients With Chronic Rhinosinusitis With Nasal Polyposis (NEZHA-2)

Not Yet Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
This is an open-label, single-arm, multicenter, extension study to evaluate the safety and efficacy of CM512 in patients With Chronic Rhinosinusitis with Nasal Polyposis
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-04-02.
Trial Details
NCT Number NCT07519577
Lead Sponsor Keymed Biosciences Co.Ltd
Conditions Chronic Rhinosinusitis With Nasal Polyposis
Enrollment 120 participants
Start Date 2026-05-31
Primary Completion 2028-05-31 (estimated)
Study Completion 2028-05-31 (estimated)
Updated on ClinicalTrials.gov 2026-06-30